GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (SHSE:688185) » Definitions » PB Ratio

CanSino Biologics (SHSE:688185) PB Ratio : 3.15 (As of Dec. 14, 2024)


View and export this data going back to 2020. Start your Free Trial

What is CanSino Biologics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-14), CanSino Biologics's share price is ¥64.39. CanSino Biologics's Book Value per Share for the quarter that ended in Jun. 2024 was ¥20.45. Hence, CanSino Biologics's PB Ratio of today is 3.15.

The historical rank and industry rank for CanSino Biologics's PB Ratio or its related term are showing as below:

SHSE:688185' s PB Ratio Range Over the Past 10 Years
Min: 0.68   Med: 0.96   Max: 2.47
Current: 1.45

During the past 8 years, CanSino Biologics's highest PB Ratio was 2.47. The lowest was 0.68. And the median was 0.96.

SHSE:688185's PB Ratio is ranked better than
67.34% of 940 companies
in the Drug Manufacturers industry
Industry Median: 2.075 vs SHSE:688185: 1.45

During the past 12 months, CanSino Biologics's average Book Value Per Share Growth Rate was -15.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -7.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 55.80% per year.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of CanSino Biologics was 147.30% per year. The lowest was -7.10% per year. And the median was 88.20% per year.

Back to Basics: PB Ratio


CanSino Biologics PB Ratio Historical Data

The historical data trend for CanSino Biologics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics PB Ratio Chart

CanSino Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial - 15.25 9.27 5.35 3.50

CanSino Biologics Quarterly Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.41 3.32 3.50 2.40 2.01

Competitive Comparison of CanSino Biologics's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, CanSino Biologics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanSino Biologics's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanSino Biologics's PB Ratio distribution charts can be found below:

* The bar in red indicates where CanSino Biologics's PB Ratio falls into.



CanSino Biologics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

CanSino Biologics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=64.39/20.447
=3.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


CanSino Biologics  (SHSE:688185) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


CanSino Biologics PB Ratio Related Terms

Thank you for viewing the detailed overview of CanSino Biologics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CanSino Biologics Business Description

Traded in Other Exchanges
Address
185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.

CanSino Biologics Headlines

No Headlines